4.7 Article

Fluorine-18-Labeled Diaryl-azines as Improved ?-Amyloid Imaging Tracers: From Bench to First-in-Human Studies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Optics

Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer's disease

Liding Zhang et al.

Summary: The early diagnosis of Alzheimer's disease can be improved by detecting multiple biomarkers. Current detection methods include cerebrospinal fluid measurement and positron-emission tomography, while recent technological advancements enable the measurement of biomarkers in blood samples.

JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review

Marianne Chapleau et al.

Summary: This article provides an up-to-date overview of the application of amyloid PET in neurodegenerative diseases, including analysis of clinical, pathological, and imaging data, comparison with other available biomarkers, and review of its use in clinical trials and clinical utility studies.

JOURNAL OF NUCLEAR MEDICINE (2022)

Review Engineering, Biomedical

Bias-generating factors in biofluid amyloid-β measurements for Alzheimer's disease diagnosis

Sohui Park et al.

Summary: Alzheimer's disease is the most common cause of dementia worldwide, however, the lack of reliable diagnostic biomarkers is a major obstacle. A beta levels in CSF and plasma show promise for early diagnosis of AD patients, but variations in concentrations within and between individuals highlight the need for reevaluation and standardization of detection methods.

BIOMEDICAL ENGINEERING LETTERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease

Feng Gao

Summary: With the advancement of technology, PET/MRI has become an important tool in studying Alzheimer's disease, showing great potential in early diagnosis and clinical assessment. Compared to traditional imaging methods, PET/MRI's superior structural resolution and image contrast make it widely applicable in neurodegenerative disease research.

EUROPEAN JOURNAL OF RADIOLOGY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Advances in Brain Amyloid Imaging

Natasha Krishnadas et al.

Summary: Amyloid-beta PET imaging has been available for over 15 years, greatly improving the clinical and research landscape of Alzheimer's disease and other neurodegenerative conditions. It has proven to be a powerful diagnostic tool and invaluable in anti-A beta therapy trials. The combination of A beta PET with comprehensive clinical evaluation by dementia-trained specialists can significantly enhance the accuracy of clinical diagnosis and alter management of AD.

SEMINARS IN NUCLEAR MEDICINE (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

PET Agents in Dementia: An Overview

Aren van Waarde et al.

Summary: This article provides an overview of PET imaging agents for research and diagnostic purposes in patients with dementia. Seven groups of tracers are distinguished based on the target they visualize, including misfolded proteins, neuroinflammation, elements of cholinergic and monoamine neurotransmitter systems. With many novel agents still in development, further advances in nuclear medicine imaging are expected in the near future.

SEMINARS IN NUCLEAR MEDICINE (2021)

Article Chemistry, Organic

Addition reactions of organic carbanion equivalents via hydrazones in water

Yi-Zhan Wang et al.

Summary: The addition of organometallic reagents to unsaturated bonds is a powerful tool for carbon-carbon bond formations but often requires stoichiometric quantity of metal and tedious anhydrous operation. In contrast, umpolung nucleophilic additions of hydrazones to Michael acceptors, carbonyls and imines in water catalyzed by ruthenium(II) can provide various alkylation products in moderate to good yields.

TETRAHEDRON (2021)

Review Biochemistry & Molecular Biology

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

Wieke M. van Oostveen et al.

Summary: This review discusses the contemporary methods of early diagnosis and longitudinal monitoring of AD using imaging techniques, examining their diagnostic utility, benefits, and limitations. Additionally, it assesses novel techniques, applications, and biomarkers for AD research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape

Bright Chukwunwike Uzuegbunam et al.

MOLECULES (2020)

Article Medicine, Research & Experimental

Discovery of Diphenoxy Derivatives with Flexible Linkers as Ligands for β-Amyloid Plaques

Jianhua Jia et al.

MOLECULAR PHARMACEUTICS (2020)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Editorial Material Clinical Neurology

NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease

Nina Silverberg et al.

ALZHEIMERS & DEMENTIA (2018)

Review Geriatrics & Gerontology

A Review of Diagnostic Impact of Amyloid Positron Emission Tomography Imaging in Clinical Practice

Yejin Kim et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease

Shizuo Hatashita et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)

Article Biochemistry & Molecular Biology

Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain

Mengchao Cui

CURRENT MEDICINAL CHEMISTRY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia

Christopher C. Rowe et al.

JOURNAL OF NUCLEAR MEDICINE (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease

Victor L. Villemagne et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand

Zsolt Cselenyi et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Psychiatry

New molecular targets for PET and SPECT imaging in neurodegenerative diseases

Marcel Benadiba et al.

REVISTA BRASILEIRA DE PSIQUIATRIA (2012)

Review Radiology, Nuclear Medicine & Medical Imaging

Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents

Chester A. Mathis et al.

SEMINARS IN NUCLEAR MEDICINE (2012)

Article Chemistry, Medicinal

18F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer's Disease: A Miniperspective

Hank F. Kung et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

Anders Jureus et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)

Dean F. Wong et al.

JOURNAL OF NUCLEAR MEDICINE (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

Natalie Nelissen et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Biochemical Research Methods

Fluoro-pegylated (FPEG) imaging agents targeting A beta aggregates

Karin A. Stephenson et al.

BIOCONJUGATE CHEMISTRY (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

F-18-labeled styrylpyridines as PET agents for amyloid plaque imaging

Wei Zhang et al.

NUCLEAR MEDICINE AND BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Rebecca Radde et al.

EMBO REPORTS (2006)

Article Chemistry, Medicinal

F-18 Stilbenes as PET imaging agents for detecting β-amyloid plaques in the brain

W Zhang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Article Clinical Neurology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

WE Klunk et al.

ANNALS OF NEUROLOGY (2004)